| (+)-alpha-tocopherol | decreases expression | ISO | RGD:3267 | 6480464 | alpha-Tocopherol results in decreased expression of PCK1 mRNA | CTD | PMID:11597575 |
| (-)-epigallocatechin 3-gallate | decreases expression | EXP | | 6480464 | epigallocatechin gallate results in decreased expression of PCK1 mRNA | CTD | PMID:15549673 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:3267 | 6480464 | epigallocatechin gallate results in decreased expression of PCK1 mRNA | CTD | PMID:16988119 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PCK1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of PCK1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | ISO | RGD:1347922 | 6480464 | Estradiol results in decreased expression of PCK1 mRNA | CTD | PMID:20106945 |
| 1H-pyrazole | decreases expression | EXP | | 6480464 | pyrazole results in decreased expression of PCK1 mRNA | CTD | PMID:17945193 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:3267 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of PCK1 protein] | CTD | PMID:19634143 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1347922 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCK1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:11882352 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1347922 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PCK1 mRNA | CTD | PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:15703265 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCK1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:11882352 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1347922 | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCK1 mRNA | CTD | PMID:20106945 PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1347922 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:21998131 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:11882352 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:15703265 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:15703265 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 protein | CTD | PMID:15703265 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:11882352 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases activity | ISO | RGD:3267 | 6480464 | Tetrachlorodibenzodioxin results in decreased activity of PCK1 protein | CTD | PMID:15703265 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PCK1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PCK1 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCK1 mRNA | CTD | PMID:18343893 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PCK1 mRNA] | CTD | PMID:11882352 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of PCK1 mRNA | CTD | PMID:17982090 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:3267 | 6480464 | 2,4-dinitrotoluene affects the expression of PCK1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:3267 | 6480464 | 2,6-dinitrotoluene affects the expression of PCK1 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | decreases expression | ISO | RGD:3267 | 6480464 | 2-Acetylaminofluorene results in decreased expression of PCK1 mRNA | CTD | PMID:16510358 |
| 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of PCK1 mRNA | CTD | PMID:19812364 |
| 3',5'-cyclic AMP | increases expression | ISO | RGD:3267 | 6480464 | Cyclic AMP results in increased expression of PCK1 mRNA | CTD | PMID:10446394 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:3267 | 6480464 | Hydrogen Peroxide inhibits the reaction [[Dexamethasone co-treated with Cyclic AMP] results in increased expression of PCK1 mRNA]; more ... | CTD | PMID:8971075 |
| 3',5'-cyclic AMP | increases expression | EXP | | 6480464 | Cyclic AMP results in increased expression of PCK1 mRNA | CTD | PMID:22117073 |
| 3',5'-cyclic AMP | increases expression | ISO | RGD:3267 | 6480464 | Cyclic AMP results in increased expression of PCK1 mRNA | CTD | PMID:10446394 PMID:2569870 |
| 3',5'-cyclic AMP | increases expression | ISO | RGD:3267 | 6480464 | Cyclic AMP results in increased expression of PCK1 mRNA | CTD | PMID:2569870 PMID:10446394 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:3267 | 6480464 | ochratoxin A inhibits the reaction [Cyclic AMP results in increased expression of PCK1 mRNA] | CTD | PMID:2569870 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PCK1 mRNA] | CTD | PMID:19467301 |
| 3-methylcholanthrene | decreases expression | ISO | RGD:3267 | 6480464 | Methylcholanthrene results in decreased expression of PCK1 mRNA | CTD | PMID:11328961 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with alitretinoin] affects the reaction [Vitamin A affects the expression of PCK1 mRNA] | CTD | PMID:16317119 |
| 9-cis-retinoic acid | increases expression | ISO | RGD:3267 | 6480464 | alitretinoin results in increased expression of PCK1 mRNA | CTD | PMID:17320364 |
| aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of PCK1 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | increases expression | ISO | RGD:1347922 | 6480464 | Aflatoxin B1 results in increased expression of PCK1 mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | decreases expression | ISO | RGD:1347922 | 6480464 | Aflatoxin B1 results in decreased expression of PCK1 mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | affects expression | ISO | RGD:1347922 | 6480464 | Aflatoxin B1 affects the expression of PCK1 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | ISO | RGD:3267 | 6480464 | Tretinoin results in increased expression of PCK1 mRNA | CTD | PMID:17320364 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with alitretinoin] affects the reaction [Vitamin A affects the expression of PCK1 mRNA] | CTD | PMID:16317119 |
| all-trans-retinol | affects expression | EXP | | 6480464 | Vitamin A affects the expression of PCK1 mRNA | CTD | PMID:16317119 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | Vitamin A affects the reaction [PPARA protein binds to PCK1 promoter] | CTD | PMID:16713227 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with alitretinoin] affects the reaction [Vitamin A affects the expression of PCK1 mRNA]; more ... | CTD | PMID:16317119 |
| alpha-linolenic acid | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with alpha-Linolenic Acid] results in increased expression of PCK1 mRNA | CTD | PMID:8536680 |
| ammonium chloride | affects expression | ISO | RGD:3267 | 6480464 | Ammonium Chloride affects the expression of PCK1 mRNA | CTD | PMID:16483693 |
| Aroclor 1254 | decreases expression | ISO | RGD:3267 | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of PCK1 mRNA | CTD | PMID:18178546 |
| arsenic atom | increases expression | ISO | RGD:1347922 | 6480464 | Arsenic results in increased expression of PCK1 protein | CTD | PMID:19818359 |
| benzo[a]pyrene | affects expression | ISO | RGD:1347922 | 6480464 | Benzo(a)pyrene affects the expression of PCK1 mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:1347922 | 6480464 | Benzo(a)pyrene results in increased expression of PCK1 mRNA | CTD | PMID:21632981 |
| benzo[a]pyrene | affects expression | ISO | RGD:1347922 | 6480464 | Benzo(a)pyrene affects the expression of PCK1 mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of PCK1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PCK1 mRNA | CTD | PMID:21715664 |
| bezafibrate | decreases expression | EXP | | 6480464 | Bezafibrate results in decreased expression of PCK1 mRNA | CTD | PMID:21549692 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of PCK1 mRNA | CTD | PMID:19245819 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PCK1 mRNA | CTD | PMID:21932408 |
| cefaloridine | decreases expression | ISO | RGD:3267 | 6480464 | Cephaloridine results in decreased expression of PCK1 mRNA | CTD | PMID:18500788 |
| chloroethene | decreases expression | EXP | | 6480464 | Vinyl Chloride results in decreased expression of PCK1 mRNA | CTD | PMID:18579281 |
| chromium atom | multiple interactions | EXP | | 6480464 | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | CTD | PMID:16940432 |
| ciglitazone | multiple interactions | ISO | RGD:1347922 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of PCK1 mRNA; more ... | CTD | PMID:16197558 |
| clofibrate | decreases expression | ISO | RGD:3267 | 6480464 | Clofibrate results in decreased expression of PCK1 mRNA | CTD | PMID:12851107 more ... |
| clofibrate | decreases expression | ISO | RGD:3267 | 6480464 | Clofibrate results in decreased expression of PCK1 mRNA | CTD | PMID:11328961 more ... |
| clofibrate | decreases expression | ISO | RGD:3267 | 6480464 | Clofibrate results in decreased expression of PCK1 mRNA | CTD | PMID:11328961 more ... |
| clofibrate | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:8536680 |
| clofibrate | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Clofibrate results in increased expression of PCK1 mRNA]; more ... | CTD | PMID:9518257 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of PCK1 mRNA; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of PCK1 mRNA | CTD | PMID:17585979 |
| copper atom | decreases expression | ISO | RGD:3267 | 6480464 | Copper results in decreased expression of PCK1 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:3267 | 6480464 | Copper results in decreased expression of PCK1 mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1347922 | 6480464 | Copper Sulfate results in decreased expression of PCK1 mRNA | CTD | PMID:19549813 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of PCK1 mRNA | CTD | PMID:18579281 |
| curcumin | decreases expression | ISO | RGD:1347922 | 6480464 | Curcumin results in decreased expression of PCK1 mRNA | CTD | PMID:17198877 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Dexamethasone results in decreased expression of PCK1 mRNA] | CTD | PMID:9518257 |
| cyclosporin A | decreases expression | ISO | RGD:1347922 | 6480464 | Cyclosporine results in decreased expression of PCK1 mRNA | CTD | PMID:20106945 |
| D-glucose | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA; more ... | CTD | PMID:8536680 |
| dexamethasone | increases expression | ISO | RGD:3267 | 6480464 | Dexamethasone results in increased expression of PCK1 mRNA | CTD | PMID:15919808 |
| dexamethasone | increases expression | ISO | RGD:3267 | 6480464 | Dexamethasone results in increased expression of PCK1 mRNA | CTD | PMID:15919808 PMID:23166830 |
| dexamethasone | increases expression | ISO | RGD:3267 | 6480464 | Dexamethasone results in increased expression of PCK1 protein | CTD | PMID:23166830 |
| dexamethasone | multiple interactions | ISO | RGD:3267 | 6480464 | [Dexamethasone co-treated with Cyclic AMP] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:8971075 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Dexamethasone results in decreased expression of PCK1 mRNA]; more ... | CTD | PMID:9518257 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of PCK1 mRNA | CTD | PMID:9518257 |
| diazoxide | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with rosiglitazone] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:9518257 |
| diazoxide | increases expression | ISO | RGD:3267 | 6480464 | Isoproterenol results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| diazoxide | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of PCK1 mRNA | CTD | PMID:17441966 |
| ethanol | increases expression | ISO | RGD:3267 | 6480464 | Ethanol results in increased expression of PCK1 mRNA | CTD | PMID:15353170 |
| fructose | increases expression | ISO | RGD:3267 | 6480464 | Fructose results in increased expression of PCK1 mRNA; more ... | CTD | PMID:19196556 |
| fructose | increases expression | ISO | RGD:3267 | 6480464 | Fructose results in increased expression of PCK1 mRNA | CTD | PMID:19196556 PMID:21212096 |
| fructose | increases activity | ISO | RGD:3267 | 6480464 | Fructose results in increased activity of PCK1 protein | CTD | PMID:21212096 |
| fructose | multiple interactions | ISO | RGD:3267 | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of PCK1 mRNA]; more ... | CTD | PMID:19196556 |
| glucose | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA; more ... | CTD | PMID:8536680 |
| glyburide | multiple interactions | ISO | RGD:3267 | 6480464 | Glyburide inhibits the reaction [Streptozocin results in increased expression of PCK1 mRNA] | CTD | PMID:20363216 |
| hydrogen peroxide | multiple interactions | ISO | RGD:3267 | 6480464 | Hydrogen Peroxide inhibits the reaction [INS1 protein results in decreased expression of PCK1 mRNA] | CTD | PMID:17213664 |
| hydrogen peroxide | multiple interactions | ISO | RGD:3267 | 6480464 | Hydrogen Peroxide inhibits the reaction [[Dexamethasone co-treated with Cyclic AMP] results in increased expression of PCK1 mRNA] | CTD | PMID:8971075 |
| hydrogen peroxide | affects expression | ISO | RGD:1347922 | 6480464 | Hydrogen Peroxide affects the expression of PCK1 mRNA | CTD | PMID:20044591 |
| iron atom | decreases expression | ISO | RGD:3267 | 6480464 | Iron deficiency results in decreased expression of PCK1 mRNA | CTD | PMID:16629162 |
| isoprenaline | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with rosiglitazone] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:9518257 |
| isoprenaline | increases expression | ISO | RGD:3267 | 6480464 | Isoproterenol results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| menadione | affects expression | ISO | RGD:1347922 | 6480464 | Vitamin K 3 affects the expression of PCK1 mRNA | CTD | PMID:20044591 |
| metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [PPARGC1A protein results in increased expression of PCK1 mRNA] | CTD | PMID:22117073 |
| methotrexate | increases expression | ISO | RGD:1347922 | 6480464 | Methotrexate results in increased expression of PCK1 mRNA | CTD | PMID:17400583 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Dexamethasone inhibits the reaction [Clofibrate results in increased expression of PCK1 mRNA]]; more ... | CTD | PMID:9518257 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3267 | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PCK1 mRNA | CTD | PMID:20360939 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:3267 | 6480464 | Dimethylnitrosamine results in decreased expression of PCK1 mRNA | CTD | PMID:17072980 |
| nicotinic acid | multiple interactions | EXP | | 6480464 | LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of PCK1 mRNA] | CTD | PMID:16940432 |
| nicotinic acid | decreases expression | ISO | RGD:3267 | 6480464 | Niacin results in decreased expression of PCK1 mRNA | CTD | PMID:20303128 |
| ochratoxin A | multiple interactions | ISO | RGD:3267 | 6480464 | ochratoxin A inhibits the reaction [Cyclic AMP results in increased expression of PCK1 mRNA] | CTD | PMID:2569870 |
| ochratoxin A | decreases expression | ISO | RGD:3267 | 6480464 | ochratoxin A results in decreased expression of PCK1 protein | CTD | PMID:3753873 |
| ochratoxin A | decreases expression | ISO | RGD:3267 | 6480464 | ochratoxin A results in decreased expression of PCK1 mRNA | CTD | PMID:3753873 PMID:6859860 |
| ochratoxin A | decreases activity | ISO | RGD:3267 | 6480464 | ochratoxin A results in decreased activity of PCK1 protein | CTD | PMID:2569870 |
| oleic acid | multiple interactions | EXP | | 6480464 | [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:8536680 |
| oleic acid | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Oleic Acid results in increased expression of PCK1 mRNA] | CTD | PMID:9518257 |
| oleic acid | increases expression | EXP | | 6480464 | Oleic Acid results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of PCK1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:1347922 | 6480464 | Acetaminophen results in decreased expression of PCK1 mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of PCK1 mRNA | CTD | PMID:17562736 |
| paraquat | multiple interactions | ISO | RGD:3267 | 6480464 | Paraquat inhibits the reaction [INS1 protein results in decreased expression of PCK1 mRNA] | CTD | PMID:17213664 |
| paraquat | increases expression | ISO | RGD:3267 | 6480464 | Paraquat results in increased expression of PCK1 mRNA | CTD | PMID:16555045 |
| perfluorooctanoic acid | increases expression | ISO | RGD:1347922 | 6480464 | perfluorooctanoic acid results in increased expression of PCK1 mRNA | CTD | PMID:21723365 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of PCK1 mRNA | CTD | PMID:19482888 PMID:19363144 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of PCK1 mRNA | CTD | PMID:23091169 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of PCK1 mRNA | CTD | PMID:19363144 PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:3267 | 6480464 | Phenobarbital results in decreased expression of PCK1 mRNA | CTD | PMID:16510358 |
| phenobarbital | increases expression | ISO | RGD:3267 | 6480464 | Phenobarbital results in increased expression of PCK1 mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases activity | ISO | RGD:3267 | 6480464 | Phenobarbital results in decreased activity of PCK1 protein | CTD | PMID:8665939 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of PCK1 mRNA | CTD | PMID:19270015 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of PCK1 mRNA] | CTD | PMID:19482888 |
| phlorizin | decreases expression | EXP | | 6480464 | Phlorhizin results in decreased expression of PCK1 mRNA | CTD | PMID:22538082 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PCK1 mRNA | CTD | PMID:17426115 |
| pirinixic acid | multiple interactions | ISO | RGD:1347922 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PCK1 mRNA | CTD | PMID:19710929 |
| prednisolone | increases expression | EXP | | 6480464 | Prednisolone results in increased expression of PCK1 mRNA | CTD | PMID:20065017 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of PCK1 mRNA | CTD | PMID:19363144 |
| quercetin | decreases expression | ISO | RGD:1347922 | 6480464 | Quercetin results in decreased expression of PCK1 mRNA | CTD | PMID:21632981 |
| quinolin-8-ol | decreases expression | ISO | RGD:1347922 | 6480464 | Oxyquinoline results in decreased expression of PCK1 mRNA | CTD | PMID:21632981 |
| resveratrol | affects expression | ISO | RGD:3267 | 6480464 | resveratrol affects the expression of PCK1 protein | CTD | PMID:17346750 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of PCK1 mRNA; more ... | CTD | PMID:19819963 |
| resveratrol | multiple interactions | ISO | RGD:3267 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in decreased expression of PCK1 mRNA] | CTD | PMID:16626303 |
| rosiglitazone | increases activity | ISO | RGD:1347922 | 6480464 | rosiglitazone results in increased activity of PCK1 protein | CTD | PMID:14739078 |
| rosiglitazone | increases expression | ISO | RGD:3267 | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:19211718 more ... |
| rosiglitazone | increases expression | ISO | RGD:3267 | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:9518257 PMID:19211718 |
| rosiglitazone | increases expression | ISO | RGD:3267 | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:19211718 PMID:9518257 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:9518257 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with rosiglitazone] results in increased expression of PCK1 mRNA; more ... | CTD | PMID:9518257 |
| rosiglitazone | increases expression | ISO | RGD:3267 | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:19211718 |
| rosiglitazone | multiple interactions | ISO | RGD:3267 | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of PCK1 mRNA]; more ... | CTD | PMID:19196556 |
| rosiglitazone | increases expression | ISO | RGD:1347922 | 6480464 | rosiglitazone results in increased expression of PCK1 mRNA | CTD | PMID:14739078 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:3267 | 6480464 | Buthionine Sulfoximine results in increased expression of PCK1 mRNA | CTD | PMID:16960379 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:3267 | 6480464 | SB 203580 inhibits the reaction [Buthionine Sulfoximine results in increased expression of PCK1 mRNA] | CTD | PMID:16960379 |
| sirolimus | multiple interactions | ISO | RGD:3267 | 6480464 | [troglitazone co-treated with Sirolimus] results in decreased expression of PCK1 mRNA | CTD | PMID:10446394 |
| sodium dichromate | decreases expression | ISO | RGD:3267 | 6480464 | sodium bichromate results in decreased expression of PCK1 mRNA | CTD | PMID:22561333 |
| streptozocin | increases expression | ISO | RGD:3267 | 6480464 | Streptozocin results in increased expression of PCK1 mRNA | CTD | PMID:12446591 |
| streptozocin | increases expression | ISO | RGD:3267 | 6480464 | Streptozocin results in increased expression of PCK1 protein | CTD | PMID:19634143 |
| streptozocin | multiple interactions | ISO | RGD:3267 | 6480464 | Trientine inhibits the reaction [Streptozocin results in increased expression of PCK1 protein] | CTD | PMID:19634143 |
| streptozocin | increases expression | ISO | RGD:3267 | 6480464 | Streptozocin results in increased expression of PCK1 mRNA | CTD | PMID:20363216 PMID:12446591 |
| streptozocin | increases expression | ISO | RGD:3267 | 6480464 | Streptozocin results in increased expression of PCK1 mRNA | CTD | PMID:12446591 PMID:20363216 |
| streptozocin | multiple interactions | ISO | RGD:3267 | 6480464 | cinnamic aldehyde inhibits the reaction [Streptozocin results in increased expression of PCK1 mRNA]; more ... | CTD | PMID:20363216 |
| streptozocin | multiple interactions | ISO | RGD:3267 | 6480464 | bis(maltolato)oxovanadium(IV) inhibits the reaction [Streptozocin results in increased expression of PCK1 mRNA] | CTD | PMID:12446591 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PCK1 mRNA | CTD | PMID:12730884 |
| thioacetamide | decreases expression | ISO | RGD:3267 | 6480464 | Thioacetamide results in decreased expression of PCK1 mRNA | CTD | PMID:16297948 |
| trans-resveratrol | affects expression | ISO | RGD:3267 | 6480464 | resveratrol affects the expression of PCK1 protein | CTD | PMID:17346750 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of PCK1 mRNA; more ... | CTD | PMID:19819963 |
| trans-resveratrol | multiple interactions | ISO | RGD:3267 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in decreased expression of PCK1 mRNA] | CTD | PMID:16626303 |
| trichloroethene | decreases expression | ISO | RGD:3267 | 6480464 | Trichloroethylene results in decreased expression of PCK1 mRNA | CTD | PMID:19448997 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PCK1 mRNA | CTD | PMID:12732648 |
| troglitazone | decreases expression | ISO | RGD:3267 | 6480464 | troglitazone results in decreased expression of PCK1 mRNA | CTD | PMID:10446394 PMID:11597575 |
| troglitazone | decreases expression | ISO | RGD:3267 | 6480464 | troglitazone results in decreased expression of PCK1 mRNA | CTD | PMID:11597575 PMID:10446394 |
| troglitazone | multiple interactions | ISO | RGD:3267 | 6480464 | [troglitazone co-treated with Sirolimus] results in decreased expression of PCK1 mRNA; more ... | CTD | PMID:10446394 |
| troglitazone | decreases expression | ISO | RGD:3267 | 6480464 | troglitazone results in decreased expression of PCK1 mRNA | CTD | PMID:11597575 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PCK1 mRNA | CTD | PMID:17292431 |
| vancomycin | increases expression | EXP | | 6480464 | Vancomycin results in increased expression of PCK1 mRNA | CTD | PMID:18930951 |
| wortmannin | multiple interactions | ISO | RGD:3267 | 6480464 | [troglitazone co-treated with wortmannin] results in decreased expression of PCK1 mRNA | CTD | PMID:10446394 |
| zinc atom | multiple interactions | ISO | RGD:1347922 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PCK1 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1347922 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PCK1 mRNA | CTD | PMID:18593933 |